FACULTY PRESENTER

Joy Eberhardt, MD, FAAP
Board Certified Pediatrician
Clinical Focus in Developmental and Behavioral Pediatrics
Halifax, Nova Scotia
Canada
PROGRAM OVERVIEW
This pediatrician‑focused online simulation program provides clinicians with information on how to recognize, evaluate, and manage developmental and epileptic encephalopathies (DEEs). Through interactive cases and evidence‑based teaching, participants learn to apply diagnostic criteria, interpret clinical assessments, and identify when referral to pediatric neurology or genetics is warranted. The program integrates current efficacy and safety data for established and emerging therapies, supporting informed treatment discussions with families. By practicing real‑world communication, management, and follow‑up strategies, pediatricians will build confidence in delivering comprehensive, family‑centered care for children with DEEs.
TARGET AUDIENCE
This educational programming will be designed for epileptologists, neurologists, primary care physicians, and pediatricians participating in the multi-disciplinary care of patients with DEEs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply diagnostic criteria, clinical assessments, and referral criteria to assess for DEEs in pediatric patients
- Incorporate clinical efficacy and safety data for current and emerging therapies into treatment discussions with pediatric patients with DEEs
- Utilize strategies for multidisciplinary, longitudinal care, and address treatment burden in pediatric patients with DEEs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this enduring activity for a maximum of 0.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Joy Eberhardt, MD, FAAP | Dr. Eberhardt De Master has nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, Medical Director for Med Learning Group, has nothing to disclose.
- Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
- Nicolas Applyrs, DO, has nothing to disclose.
- Andi Koral, MS, CMP-HC, Program Manager for Med Learning Group, has nothing to disclose.
- Russie Allen, M.M., Accreditation & Outcomes Manager, for Med Learning Group, has nothing to disclose.
- Elizabeth Griffin, Program Coordinator for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 02, 2026
EXPIRATION DATE: November 02, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY PRESENTER

Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
Orange, California
PROGRAM OVERVIEW
This primary care–focused online simulation program prepares clinicians to identify and manage developmental and epileptic encephalopathies (DEEs). Participants will better understand how to apply diagnostic criteria, conduct clinical assessments, and determining appropriate referral pathways for both pediatric and adult patients. The curriculum integrates current data for established and emerging therapies to support evidence‑based treatment discussions with adults living with DEEs. Learning modules emphasize the PCP’s role in coordinating multidisciplinary services, guiding transition from pediatric to adult care, and reducing polypharmacy through regular medication review and collaborative management strategies.
TARGET AUDIENCE
This educational programming will be designed for epileptologists, neurologists, primary care physicians, and pediatricians participating in the multi-disciplinary care of patients with DEEs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Utilize diagnostic criteria, clinical assessments, and referral criteria to assess for DEEs in adults
- Integrate clinical efficacy and safety data for current and emerging therapies into treatment discussions with adults with DEEs
- Incorporate processes to provide multidisciplinary, longitudinal care that includes the transition from pediatric care, and reduce polypharmacy in adults with DEEs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Charles Vega, MD, FAAFP | Dr. Vega discloses he is a consultant for Abbott, Boehringer Ingelheim, and Lilly. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, Medical Director for Med Learning Group, has nothing to disclose.
- Nicolas Applyrs Jr, DO, MS, MPH, has nothing to disclose.
- Melinda Chang, NP, has nothing to disclose.
- Laura Servinsky has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Andi Koral, MS, CMP-HC, Program Manager for Med Learning Group, has nothing to disclose.
- Russie Allen, M.M., Accreditation & Outcomes Manager, for Med Learning Group, has nothing to disclose.
- Elizabeth Griffin, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 02, 2026
EXPIRATION DATE: November 02, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY PRESENTER

Patricia Dugan, MD, FAES
Professor of Neurology
Director, Adult Epilepsy
NYU Langone Health
Comprehensive Epilepsy Center
New York, New York
PROGRAM OVERVIEW
This neurology and epileptology–focused online simulation program enhances specialist proficiency in evaluating and managing adults with developmental and epileptic encephalopathies (DEEs). Through immersive, scenario‑based modules, participants refine the use of molecular testing, EEG interpretation, and differential diagnostic tools to improve diagnostic accuracy. The curriculum integrates clinical data for current and emerging therapies to support personalized treatment selection and optimize seizure and non‑seizure outcomes. The program will also address multidisciplinary coordination, structured transition processes, and evidence‑based strategies to reduce polypharmacy and improve long‑term quality of life for adults with DEEs.
TARGET AUDIENCE
This educational programming will be designed for epileptologists, neurologists, primary care physicians, and pediatricians participating in the multi-disciplinary care of patients with DEEs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Incorporate diagnostic tools and best practices for molecular testing, EEG, and differential diagnosis in adults
- Utilize clinical efficacy and safety data and trials designs for current and emerging therapies to inform personalized treatment selection and improve seizure and non-seizure outcomes
- Apply strategies for multidisciplinary, longitudinal care and reduce polypharmacy in adults with DEEs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this enduring activity for a maximum of 0.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Patricia Dugan, MD, FAES | Dr. Dugan discloses that she served as a consultant for Eli Lilly and NeuroPace. Dr. Dugan has also served on the Speakers Bureau for NeuroPace and has conducted research for NIH. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, Medical Director for Med Learning Group, has nothing to disclose.
- La Donna Lue Winston, MSN, APRN, AGACNP-BC, SCRN, RN, has nothing to disclose.
- Laura Servinsky has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Andi Koral, MS, CMP-HC, Program Manager for Med Learning Group, has nothing to disclose.
- Russie Allen, M.M., Accreditation & Outcomes Manager, for Med Learning Group, has nothing to disclose.
- Elizabeth Griffin, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 02, 2026
EXPIRATION DATE: November 02, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.